结果表明：硬脂酸与戊胺等摩尔充分混合后，生成硬脂酸戊铵盐， 体系中残存的少量硬脂酸与其戊铵盐形成酸盐结构。
The results indicated that after mixing the two reactants together, pentyl ammonium stearate was created and it formed acid-salt structure with the stearic acid remained.
以硬脂酸(SA)和二乙醇胺(DEA)为原料，在自制催化剂的催化下合成了一种脂肪烷醇酰胺类非离子型抗静电剂。
A new non-ionic antistatic agent of fat alkanolamide was synthesized by reacted stearic acid (SA) and alkanolamide (DEA), and the effect of reaction conditions on the yield were studied.
以密胺树脂为壳材、结晶紫内酯-硬脂酸-十四醇组成的热敏变色材料为芯材，采用原位聚合法制备热敏变色微胶囊。
The abamectin microcapsules were prepared by in-situ polymerization process in this work, with melamine-formaldehyde resin and urea-formaldehyde resin as wall materials respectively.
以密胺树脂为壳材、结晶紫内酯-硬脂酸-十四醇组成的热敏变色材料为芯材，采用原位聚合法制备热敏变色微胶囊。
The photochromic microcapsules were prepared by in-situ polymerization, using melamine-formaldehyde resin as wall materials and photochromic materials as core materials.
组合物中还包括硬脂酸、二甘醇、三乙醇胺、白炭黑、天然橡胶或合成橡胶胶乳等辅料。
The composition further comprises stearic acid, diethylene glycol, triethanolamine, white carbon black, natural rubber or synthetic rubber latex and other auxiliary materials.
方法：以空白丸芯、柠檬酸三乙酯、滑石粉、硬脂酸镁、胶体二氧化硅、聚维酮K30等为骨架材料制备吲达帕胺缓释胶囊；
Methods: Using eudragitrs 100, triethyl citrate, hydrated magnesium silicate, magnesium stearate, silicic acid anhydride, povidone K30 and etc as capsules preparation materials.
本文以硬脂酸丁酯为相变材料，蜜胺树脂为壁材，采用原位聚合法制备了微胶囊相变材料。
Microencapsulated phase change material was prepared by situ polymerization with butyl stearate as phase change material, melamine-formaldehyde resin as wall material.
本文以硬脂酸丁酯为相变材料，蜜胺树脂为壁材，采用原位聚合法制备了微胶囊相变材料。
Microencapsulated phase change material was prepared by situ polymerization with butyl stearate as phase change material, melamine-formaldehyde resin as wall material.
应用推荐